University of Minnesota, Minneapolis, Minnesota.
University of Virginia School of Medicine, Charlottesville, Virginia.
Surg Technol Int. 2021 May 20;38:371-378. doi: 10.52198/21.STI.38.OS1437.
There are many treatment options for patients who have osteonecrosis of the femoral head (ONFH) and management strategies vary widely both among and within individual countries. Although many researchers have attempted to elucidate the optimal strategies for managing this disease, the lack of large-scale randomized control trials and the lack of agreement on disease staging have curtailed the development of clear-cut guidelines.
The Association Research Circulation Osseous (ARCO) group sought to address three questions for the management of patients who have ONFH: 1) What imaging studies are most sensitive and specific for the diagnostic evaluation of patients who have ONFH?; 2) What is the best treatment strategy for preventing disease progression in patients who have pre-collapse lesions?; and 3) What is the best treatment strategy for patients who have post-collapse disease? The Patient, Intervention, Comparison, and Outcome (PICO) format was used to formulate the search strategy for each research question. A systematic review will be performed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. ARCO participants have been allocated to three groups, each representing one of the PICO questions. After qualitative and quantitative analysis of the data extracted from studies pertaining to each of the three research questions, a set of evidence-based clinical practice guidelines will be proposed for the management of patients who have ONFH.
It is not always clear which treatment method is optimal for the management of ONFH. Thus, many surgeons have developed and performed various procedures based on patient-specific factors. As there is no consensus on the optimal treatment for various stages of disease, it was clear that developing evidence-based clinical practice guidelines would provide more structure and uniformity to management of these patients. Therefore, the results of this systematic review will lead to the development guidelines that may improve patient-care strategies and result in better outcomes for patients who have ONFH.
对于患有股骨头坏死(ONFH)的患者,有许多治疗选择,管理策略在各国之间和各国内部差异很大。尽管许多研究人员试图阐明管理这种疾病的最佳策略,但缺乏大规模的随机对照试验以及对疾病分期的缺乏共识,限制了明确指南的发展。
协会研究循环骨骼(ARCO)小组试图为患有 ONFH 的患者的管理解决三个问题:1)哪些影像学研究对患有 ONFH 的患者的诊断评估最敏感和最特异?; 2)对于有塌陷前病变的患者,预防疾病进展的最佳治疗策略是什么?; 3)对于有塌陷后疾病的患者,最佳治疗策略是什么?采用患者、干预、比较和结局(PICO)格式为每个研究问题制定搜索策略。将根据系统评价和荟萃分析的首选报告项目(PRISMA)指南进行系统评价。ARCO 参与者被分配到三个小组,每个小组代表 PICO 问题之一。对与三个研究问题中的每一个相关的研究中提取的数据进行定性和定量分析后,将为患有 ONFH 的患者提出一套基于证据的临床实践指南。
对于 ONFH 的管理,哪种治疗方法是最佳的并不总是清楚。因此,许多外科医生根据患者的具体因素开发并实施了各种程序。由于对疾病各个阶段的最佳治疗方法没有共识,因此很明显,制定基于证据的临床实践指南将为这些患者的管理提供更多的结构和统一性。因此,这项系统评价的结果将导致制定指南,这些指南可能会改善患者护理策略,并为患有 ONFH 的患者带来更好的结果。